IBDEI06K ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2744,1,3,0)
 ;;=3^Eosinophilia
 ;;^UTILITY(U,$J,358.3,2744,1,4,0)
 ;;=4^D72.1
 ;;^UTILITY(U,$J,358.3,2744,2)
 ;;=^41173
 ;;^UTILITY(U,$J,358.3,2745,0)
 ;;=R73.09^^18^207^31
 ;;^UTILITY(U,$J,358.3,2745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2745,1,3,0)
 ;;=3^Glucose,Abnormal (HgbA1c)
 ;;^UTILITY(U,$J,358.3,2745,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,2745,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,2746,0)
 ;;=R58.^^18^207^32
 ;;^UTILITY(U,$J,358.3,2746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2746,1,3,0)
 ;;=3^Hemorrhage NEC
 ;;^UTILITY(U,$J,358.3,2746,1,4,0)
 ;;=4^R58.
 ;;^UTILITY(U,$J,358.3,2746,2)
 ;;=^5019528
 ;;^UTILITY(U,$J,358.3,2747,0)
 ;;=E88.09^^18^207^33
 ;;^UTILITY(U,$J,358.3,2747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2747,1,3,0)
 ;;=3^Hypoalbuminemia NEC
 ;;^UTILITY(U,$J,358.3,2747,1,4,0)
 ;;=4^E88.09
 ;;^UTILITY(U,$J,358.3,2747,2)
 ;;=^5003027
 ;;^UTILITY(U,$J,358.3,2748,0)
 ;;=D70.9^^18^207^34
 ;;^UTILITY(U,$J,358.3,2748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2748,1,3,0)
 ;;=3^Neutropenia,Unspec
 ;;^UTILITY(U,$J,358.3,2748,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,2748,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,2749,0)
 ;;=D72.819^^18^207^35
 ;;^UTILITY(U,$J,358.3,2749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2749,1,3,0)
 ;;=3^White Blood Cell Count,Decreased,Unspec
 ;;^UTILITY(U,$J,358.3,2749,1,4,0)
 ;;=4^D72.819
 ;;^UTILITY(U,$J,358.3,2749,2)
 ;;=^5002376
 ;;^UTILITY(U,$J,358.3,2750,0)
 ;;=D72.829^^18^207^36
 ;;^UTILITY(U,$J,358.3,2750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2750,1,3,0)
 ;;=3^White Blood Cell Count,Elevated,Unspec
 ;;^UTILITY(U,$J,358.3,2750,1,4,0)
 ;;=4^D72.829
 ;;^UTILITY(U,$J,358.3,2750,2)
 ;;=^5002379
 ;;^UTILITY(U,$J,358.3,2751,0)
 ;;=D72.9^^18^207^37
 ;;^UTILITY(U,$J,358.3,2751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2751,1,3,0)
 ;;=3^White Blood Cells Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,2751,1,4,0)
 ;;=4^D72.9
 ;;^UTILITY(U,$J,358.3,2751,2)
 ;;=^5002381
 ;;^UTILITY(U,$J,358.3,2752,0)
 ;;=L02.91^^18^208^1
 ;;^UTILITY(U,$J,358.3,2752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2752,1,3,0)
 ;;=3^Abcess,Cutaneous,Unspec
 ;;^UTILITY(U,$J,358.3,2752,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,2752,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,2753,0)
 ;;=L11.9^^18^208^2
 ;;^UTILITY(U,$J,358.3,2753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2753,1,3,0)
 ;;=3^Acantholytic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,2753,1,4,0)
 ;;=4^L11.9
 ;;^UTILITY(U,$J,358.3,2753,2)
 ;;=^5009094
 ;;^UTILITY(U,$J,358.3,2754,0)
 ;;=L83.^^18^208^3
 ;;^UTILITY(U,$J,358.3,2754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2754,1,3,0)
 ;;=3^Acanthosis Nigricans
 ;;^UTILITY(U,$J,358.3,2754,1,4,0)
 ;;=4^L83.
 ;;^UTILITY(U,$J,358.3,2754,2)
 ;;=^1451
 ;;^UTILITY(U,$J,358.3,2755,0)
 ;;=L70.9^^18^208^4
 ;;^UTILITY(U,$J,358.3,2755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2755,1,3,0)
 ;;=3^Acne,Unspec
 ;;^UTILITY(U,$J,358.3,2755,1,4,0)
 ;;=4^L70.9
 ;;^UTILITY(U,$J,358.3,2755,2)
 ;;=^5009273
 ;;^UTILITY(U,$J,358.3,2756,0)
 ;;=L57.0^^18^208^5
 ;;^UTILITY(U,$J,358.3,2756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2756,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,2756,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,2756,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,2757,0)
 ;;=N65.0^^18^208^16
 ;;^UTILITY(U,$J,358.3,2757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2757,1,3,0)
 ;;=3^Breast,Reconstructed Deformity
 ;;^UTILITY(U,$J,358.3,2757,1,4,0)
 ;;=4^N65.0
 ;;^UTILITY(U,$J,358.3,2757,2)
 ;;=^5015800
 ;;^UTILITY(U,$J,358.3,2758,0)
 ;;=N64.9^^18^208^9
